Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 01:30:00 11/04/2026 am IST			5-day change	1st Jan Change
50.96 ^USD	-0.62%		+3.58%	+72.80%

09/04	US CDC delays publishing report showing COVID vaccine benefits, WaPo reports	RE
09/04	US CDC delays publishing report showing Covid-19 vaccine benefits, Washington Post reports	RE

Transcript : Moderna, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 09

Published on 03/10/2026 at 08:05 pm IST - Modified on 03/10/2026 at 09:05 pm IST

S&P Capital IQ

Presenter Speech
Eliana Merle (Analysts)

Hi, guys. Good morning. Welcome to sunny Miami. I'm Ellie Merle, one of the biotech analysts here at Barclays. Very happy to have Lavina Talukdar here with us

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Moderna, Inc.

09/04	US CDC delays publishing report showing COVID vaccine benefits, WaPo reports	RE
09/04	US CDC delays publishing report showing Covid-19 vaccine benefits, Washington Post reports	RE
07/04	RBC Adjusts Price Target on Moderna to $35 From $30, Maintains Sector Perform Rating	MT
01/04	Barclays Adjusts Price Target on Moderna to $48 From $25, Maintains Equalweight Rating	MT
01/04	Rare disease advocacy group urges Trump administration to restore FDA clarity	RE
23/03	Arbutus Biopharma 2025 Net Loss Narrows as Revenue Rises	MT
18/03	Deutsche Bank Adjusts Moderna Price Target to $45 From $28, Maintains Hold Rating	MT
17/03	Moderna says CEO Stéphane Bancel's 2025 total compensation was $19.9 million - SEC filing	RE
17/03	US Health Secretary Kennedy's vaccine actions and policy positions	RE
13/03	GSK gets US FDA approval for expanded use of RSV vaccine	RE
10/03	Moderna, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 09:30 AM
05/03	Berenberg Raises Price Target on Moderna to $45 From $32, Keeps Hold Rating	MT
05/03	US stocks close up on Iran diplomacy hopes; tech leads rebound	RE
05/03	Health Care Up, But not by Much, on Cyclical Bias - Health Care Roundup	DJ
05/03	Equities Rise on Upbeat Data as Markets Look Past Middle East Conflict	MT